Iranian Red Crescent Medical Journal

Published by: Kowsar

Pathway Crosstalk Network Analysis Provides Insight Into Novel Pathways in Breast Cancer

Jin Zheng 1 , Hong Chen 2 , Ying Pan 1 and Xin Yue 3 , *
Authors Information
1 Breast Surgery, Lishui Central Hospital, Lishui 323000, Zhejiang Province, China
2 Department of Infection Control, Xi ‘an Hospital of Traditional Chinese Medicine, Xi-an 710021, Shaanxi Province, China
3 Department of Oncological Surgery, The First People’s Hospital of Jingzhou City, Jingzhou 434000, Hubei Province, China
Article information
  • Iranian Red Crescent Medical Journal: October 2017, 19 (10); e12901
  • Published Online: September 5, 2017
  • Article Type: Research Article
  • Received: March 15, 2017
  • Revised: May 9, 2017
  • Accepted: July 18, 2017
  • DOI: 10.5812/ircmj.12901

To Cite: Zheng J, Chen H, Pan Y, Yue X. Pathway Crosstalk Network Analysis Provides Insight Into Novel Pathways in Breast Cancer, Iran Red Crescent Med J. 2017 ; 19(10):e12901. doi: 10.5812/ircmj.12901.

Copyright © 2017, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. McGuire S. World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr. 2016; 7(2): 418-9[DOI][PubMed]
  • 2. Chacon RD, Costanzo MV. Triple-negative breast cancer. Breast Cancer Res. 2010; 12 Suppl 2[DOI][PubMed]
  • 3. Mar-Aguilar F, Mendoza-Ramirez JA, Malagon-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, et al. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis Markers. 2013; 34(3): 163-9[DOI][PubMed]
  • 4. Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004; 116(6): 855-67[PubMed]
  • 5. Khatri P, Sirota M, Butte AJ. Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol. 2012; 8(2)[DOI][PubMed]
  • 6. Zhai DK, Liu B, Bai XF, Wen JA. Identification of biomarkers and pathway-related modules involved in ovarian cancer based on topological centralities. J BUON. 2016; 21(1): 208-20[PubMed]
  • 7. Donato M, Xu Z, Tomoiaga A, Granneman JG, Mackenzie RG, Bao R, et al. Analysis and correction of crosstalk effects in pathway analysis. Genome Res. 2013; 23(11): 1885-93[DOI][PubMed]
  • 8. Li Y, Agarwal P. A pathway-based view of human diseases and disease relationships. PLoS One. 2009; 4(2)[DOI][PubMed]
  • 9. Xia Y, Yu H, Jansen R, Seringhaus M, Baxter S, Greenbaum D, et al. Analyzing cellular biochemistry in terms of molecular networks. Annu Rev Biochem. 2004; 73: 1051-87[DOI][PubMed]
  • 10. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet. 2004; 5(2): 101-13[DOI][PubMed]
  • 11. Chen DT, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, et al. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat. 2010; 119(2): 335-46[DOI][PubMed]
  • 12. Robbins P, Pinder S, de Klerk N, Dawkins H, Harvey J, Sterrett G, et al. Histological grading of breast carcinomas: A study of interobserver agreement. Human Pathol. 1995; 26(8): 873-9[DOI]
  • 13. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003; 31(4)[PubMed]
  • 14. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003; 19(2): 185-93[PubMed]
  • 15. Giorgi FM, Bolger AM, Lohse M, Usadel B. Algorithm-driven artifacts in median polish summarization of microarray data. BMC Bioinformatics. 2010; 11: 553[DOI][PubMed]
  • 16. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11): 2498-504[DOI][PubMed]
  • 17. Li Y, Agarwal P, Rajagopalan D. A global pathway crosstalk network. Bioinformatics. 2008; 24(12): 1442-7[DOI][PubMed]
  • 18. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal Royal Statistical Soc. 1995; : 289-300
  • 19. Prifti E, Zucker JD, Clement K, Henegar C. Interactional and functional centrality in transcriptional co-expression networks. Bioinformatics. 2010; 26(24): 3083-9[DOI][PubMed]
  • 20. Otte E, Rousseau R. Social network analysis: a powerful strategy, also for the information sciences. J Inf Sci. 2002; 28(6): 441-53
  • 21. Rank Product method for identifying differentially expressed genes with application in meta-analysis. 2015;
  • 22. Wilson CL, Sims AH, Howell A, Miller CJ, Clarke RB. Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer. 2006; 13(2): 617-28[DOI][PubMed]
  • 23. Breitling R, Herzyk P. Rank-based methods as a non-parametric alternative of the T-statistic for the analysis of biological microarray data. J Bioinform Comput Biol. 2005; 3(5): 1171-89[PubMed]
  • 24. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, et al. A systems biology approach for pathway level analysis. Genome Res. 2007; 17(10): 1537-45[DOI][PubMed]
  • 25. Zhang YX, Zhao YL. Pathogenic Network Analysis Predicts Candidate Genes for Cervical Cancer. Comput Math Methods Med. 2016; 2016: 3186051[DOI][PubMed]
  • 26. Liu H, Han X, Li Y. Identifying disrupted pathways by tracking altered modules in type 2 DM-related heart failure. Herz. 2017; 42(1): 98-106[DOI][PubMed]
  • 27. Li C, Li X, Miao Y, Wang Q, Jiang W, Xu C, et al. SubpathwayMiner: a software package for flexible identification of pathways. Nucleic Acids Res. 2009; 37(19)[DOI][PubMed]
  • 28. Icard P, Lincet H. A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. Biochim Biophys Acta. 2012; 1826(2): 423-33[DOI][PubMed]
  • 29. Munoz-Pinedo C, El Mjiyad N, Ricci JE. Cancer metabolism: current perspectives and future directions. Cell Death Dis. 2012; 3[DOI][PubMed]
  • 30. Schell JC, Olson KA, Jiang L, Hawkins AJ, Van Vranken JG, Xie J, et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell. 2014; 56(3): 400-13[DOI][PubMed]
  • 31. Dong C, Yuan T, Wu Y, Wang Y, Fan TW, Miriyala S, et al. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell. 2013; 23(3): 316-31[DOI][PubMed]
  • 32. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009; 324(5930): 1029-33[DOI][PubMed]
  • 33. Zhao Y, Butler EB, Tan M. Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis. 2013; 4[DOI][PubMed]
  • 34. Lu H, Dalgard CL, Mohyeldin A, McFate T, Tait AS, Verma A. Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem. 2005; 280(51): 41928-39[DOI][PubMed]
  • 35. Lopez-Lazaro M. Hypoxia-inducible factor 1 as a possible target for cancer chemoprevention. Cancer Epidemiol Biomarkers Prev. 2006; 15(12): 2332-5[DOI][PubMed]
  • 36. Ciavardelli D, Rossi C, Barcaroli D, Volpe S, Consalvo A, Zucchelli M, et al. Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment. Cell Death Dis. 2014; 5[DOI][PubMed]
  • 37. Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 2009; 69(4): 1302-13
  • 38. Reyes RK, Motiwala T, Jacob ST. Regulation of glucose metabolism in hepatocarcinogenesis by microRNAs. Gene Expr. 2014; 16(2): 85-92[DOI][PubMed]
  • 39. Bajaj A, Driver JA, Schernhammer ES. Parkinson's disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control. 2010; 21(5): 697-707[DOI][PubMed]
  • 40. Driver JA, Lu KP. Pin1: a new genetic link between Alzheimer's disease, cancer and aging. Curr Aging Sci. 2010; 3(3): 158-65[PubMed]
  • 41. Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, et al. Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ. 2012; 344[DOI][PubMed]
  • 42. Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology. 2010; 74(2): 106-12[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments